… a risk, particularly in institutions that are unable to provide UD preservative-free nebulization
… Additionally, the work required to produce a concentration of 160 mg of albuterol in 240 mL …

… given in the clinical setting are bronchodilators.12 … of nebulized bronchodilator therapy
over handheld devices in patients who can use them properly.2 Due to equivalence, nebulized …

… Publication bias was assessed qualitatively by visual inspection of the funnel plot and … [6]
reported that inhaled LAMA significantly increased the risk of MACE by 58% in COPD …

… higher-dose combination group than in the albuterol-alone group (hazard ratio, 0.74; 95% …
A fixed-dose combination of inhaled albuterol and budesonide, as compared with albuterol …

… Inhaled corticosteroids (ICS), when used in combination with long-acting bronchodilators,
reduce the risk … Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-…

… (pMDI) as a bronchodilator for asthma, was … use of inhaled bronchodilators [5, 6] and so
delayed in seeking medical advice, even if not proved, resulted in suspending the use of inhaled …

… Publication bias was qualitatively evaluated by a visual funnel diagram, … inhaled
bronchodilators may have a synergistic effect on inhaled glucocorticoids, and inhaled …

… on the basis of a direct increase in risk of AAC as a consequence of … inhaled or nebulized
bronchodilators used to treat asthma or other chronic upper airway diseases. Bronchodilators …

… Inhaled corticosteroids (ICSs) combined with long-acting bronchodilators are indicated for
patients … Finally, we could not find clear evidence of increased risk of sepsis, eye disorders, …

… patients requiring inhaled bronchodilators during affection of … of the drugs, especially
albuterol. There also has been … the risk of transmission of infection directly from nebulization …